(Q34111941)

31 July 2017

0 references

1 reference

title

Increased risk of invasive bacterial infections in African people with sickle-cell disease: a systematic review and meta-analysis (English)

1 reference

31 July 2017

0 references

0 references

1 reference

3

Keith P Klugman

1 reference

31 July 2017

7

Orin S Levine

1 reference

31 July 2017

2

Jennifer C Moïsi

1 reference

31 July 2017

author name string

Meenakshi Ramakrishnan

1

1 reference

31 July 2017

Jesus M Feris Iglesias

4

1 reference

31 July 2017

Lindsay R Grant

5

1 reference

31 July 2017

Mireille Mpoudi-Etame

6

1 reference

31 July 2017

publication date

1 May 2010

1 reference

Lancet Infectious Diseases

31 July 2017

published in

1 reference

31 July 2017

volume

10

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

329-337

1 reference

Global epidemiology of haemoglobin disorders and derived service indicators

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Mortality from sickle cell disease in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

A case for developing North-South partnerships for research in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Acute sickle cell syndromes in Nigerian adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

[Bacterial infections in children with sickle cell disease in Libreville]

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Sickle cell disease in Africa: burden and research priorities

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

The presentation, management and prophylaxis of sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Morbidity of sickle cell disease in early childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Infection Caused by Streptococcus pneumoniae in Children with Sickle Cell Disease: Epidemiology, Immunologic Mechanisms, Prophylaxis, and Vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Mortality in sickle cell disease. Life expectancy and risk factors for early death.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Bacteraemia in homozygous sickle cell disease in Africa: is pneumococcal prophylaxis justified?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Acute illness in Nigerian children with sickle cell anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Bacteremia in sickle hemoglobinopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Sequelae due to bacterial meningitis among African children: a systematic literature review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Pattern of bacteraemia in febrile children with sickle cell anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Variation in the pattern of bacterial infection in patients with sickle cell disease requiring admission

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Incidence of bacteraemia among children with severe anaemia in Wesley Guild Hospital, Ilesa, Nigeria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Abnormal Distribution of Haemoglobin Genotypes in Negro Children with Severe Bacterial Infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Sickle cell disease in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Clinical presentation of severe anemia in pediatric patients with sickle cell anemia seen in Enugu, Nigeria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Comparison of an Opsonophagocytic Assay and IgG ELISA to Assess Responses to Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccines in Children and Young Adults with Sickle Cell Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Pneumococcal vaccines for sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: community-based observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970055-4

7 January 2021

10.1016/S1473-3099(10)70055-4

Identifiers

DOI

1 reference

31 July 2017

1 reference